Abstract: Disclosed is a method for the preparation of 8-methoxy-4,8-dimethyl-1-(4-isopropylphenyl)-nonane which comprises the steps of(a) reacting para-isopropylbenzyl chloride with triphenylphosphine in the presence of a suitable solvent for a sufficient period of time and at a sufficient temperature to form an intermediate product in solution, para-isopropylbenzyl triphenylphosphonium chloride, and(b) reacting said solution with sodium methoxide, followed by methoxycitronellal to produce cis- and trans-8-methoxy-4,8-dimethyl-1-(4-isopropylphenyl)-1-nonene,(c) separating said intermediate product from the residual reactants, and(d) hydrogenating said cis- and trans-8-methoxy-4,8-1-(4-isopropylphenyl)-1-nonene, in the presence of a suitable solvent and catalyst to form 8-methoxy-4,8-dimethyl-1-(4-isopropylphenyl)-nonane.
Abstract: Process of radioimaging the myocardium of mammals using intravenous injection of radiolabeled lipophilic cations of quaternary ammonium, quaternary phosphonium or quaternary arsonium compounds of the formula ##STR1## where R.sub.1 and R.sub.2 are alkyl or aryl groups, R.sub.3 and R.sub.4 are phenyl or benzyl groups, X is Br.sup.-, I.sup.- or Cl.sup.-, L is I.sup.123, I.sup.125, I.sup.131, Br.sup.77, Br.sup.82 or F.sup.18 and Z is nitrogen, phosphorous or arsenic.
Abstract: The disclosure relates to a process for purifying and recovering a contaminated catalyst solution which is obtained in the carbonylation of methyl acetate and/or dimethylether, the catalyst solution containing carbonyl complexes of noble metals of group VIII of the Periodic System of the elements, quaternary heterocyclic aromatic nitrogen compounds or quaternary organophosphorus compounds as organic promoters, undistillable organic contaminants as well as acetic acid, acetic anhydride and ethylidene diacetate.
Type:
Grant
Filed:
July 29, 1982
Date of Patent:
April 3, 1984
Assignee:
Hoechst Aktiengesellschaft
Inventors:
Heinz Erpenbach, Klaus Gehrmann, Winfried Lork, Peter Prinz
Abstract: Process for producing organic tertiary polyphosphine monooxides which comprises reacting an organic tertiary polyphosphine with an organic monofunctional alkylating agent to form an intermediate monophosphonium salt of the polyphosphine starting material and then hydrolyzing the salt so produced to the desired polyphosphine monooxide product.
Type:
Grant
Filed:
August 17, 1981
Date of Patent:
January 31, 1984
Assignee:
Union Carbide Corporation
Inventors:
Anthony G. Abatjoglou, Louis A. Kapicak
Abstract: Metal or metalloid salts, ansolvo-acids and proton-acids can be so complexed with 1,2,3-triols, glycerol ethers or glycerol thioethers containing at least 6 C atoms in the molecule that they are in the form of compositions which are soluble in organic solvents, especially non-polar, aprotic solvents, such as hydrocarbons. These stable compositions display an outstanding anti-static action and, because of their spectrum of properties, are especially suitable for imparting anti-static characteristics to polymers, lubricants, fuels and also solvents based on hydrocarbons.
Type:
Grant
Filed:
September 7, 1977
Date of Patent:
September 13, 1983
Assignee:
Ciba-Geigy Corporation
Inventors:
Hermann O. Wirth, Hans-Helmut Friedrich
Abstract: There are provided novel sulfonated group Va ylides defined by the following Formula I: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.
Abstract: Hydroxy-substituted phosphoranes and salts thereof represented by Formulae I and II ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different members of the group consisting of lower alkyl, C.sub.5 -C.sub.6 cycloalkyl, and ##STR2## wherein q is an integer from 0 to 4 and Y is selected from the group consisting of hydrogen, halogen, lower alkyl and lower alkoxy; R.sub.4 can be hydrogen or C.sub.1 -C.sub.3 straight or branched chain alkyl; the sum of n+m=3-5; R.sub.5 is hydrogen or lower alkyl; R.sub.6 and R.sub.7 are the same or different members of the group consisting of hydrogen, lower alkyl, and ##STR3## p is an integer of 0 or 1; and X is an anion. The compounds are useful as intermediates for the heterocyclic phosphonium salts disclosed and claimed in U.S. Pat. No. 4,075,407. An improved process for preparing the phosphonium salts of U.S. Pat. No. 4,075,407 is also provided by the present invention.
Abstract: 1-Aryloxy-2-(S)-hydroxy-3-(triarylphosphonio)-propane salts and alkali metal ylids thereof are novel intermediates useful in the direct synthesis of 15-(R)-hydroxy-16-aryloxy-prostaglandins.
Abstract: A process for asymmetrically hydrogenating through the use of microorganisms a double bond connected to tertiary carbon atom in an olefinic aliphatic compound to produce a tertiary, optically active aliphatic compound useful as an intermediate for optically active Vitamins E and K.
Type:
Grant
Filed:
November 24, 1978
Date of Patent:
December 15, 1981
Assignee:
Hoffmann-La Roche, Inc.
Inventors:
Richard Barner, Walter Boguth, Hans G. W. Leuenberger, Max Schmid, Reinhard Zell
Abstract: A new group of nickel ylides is provided that is highly active at relatively low operating temperatures and pressures in the oligomerization of ethylene. The compounds can be defined by the following Formula I: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7 and R.sub.
Abstract: New derivatives of 8-dehydro-vitamin A obtained by vinylating or ethynylating and subsequently partially hydrogenating, 1-[3-methyl-octa-1-yne,3,5,-dien-7-on-1-yl]-2,6-dimethyl-cyclohex-1-ene or its 5- and/or 6-methyl derivatives, converting the resulting alcohols to the corresponding derivatives of 8-dehydro-vitamin A halides by reacting with thionyl chloride or phosgene, and if required converting the resulting alcohols or halides to the corresponding trialkylphosphonium salts or triarylphosphonium salts, or reacting the 8-dehydro-vitamin A halide derivatives with alkali metal salts or alkaline earth metal salts or anhydrides of lower carboxylic acids. The new compounds can be partially hydrogenated to the corresponding polyene compounds, in which case the cis-trans isomer mixtures first obtained can be rearranged in the conventional manner to the physiologically active all-trans compounds.
Abstract: Tri(phenyl)alkyl phosphonium halides wherein the phenyl groups contain a long chain or sterically hindered alkyl group are novel and exhibit efficacious levels of fungicidal and bacteriocidal activity. The presence of the alkyl substituent eliminates or significantly reduces the phytotoxicity that characterizes the corresponding unsubstituted phosphonium compounds.